Uterine fibroids are a major cause of morbidity in women of a reproductive age (and
sometimes even after menopause). There are several factors that are attributed to underlie …

In the continuous search for cancer therapies with a higher therapeutic window, localized
temperature-induced drug delivery may offer a minimal invasive treatment option. Here, a …

Ultrasound (US) imaging is an exquisite tool for the non-invasive and real-time diagnosis of
many different diseases. In this context, US contrast agents can improve lesion delineation …

The blood–brain barrier (BBB) limits drug delivery to the central nervous system. When
combined with microbubbles, ultrasound can transiently permeate blood vessels in the …

With the development of nanotechnology, nanocarriers have been increasingly used for
curative drug/gene delivery. Various nanocarriers are being introduced and assessed, such …

Purpose: Mild hyperthermia (40–45° C) is a proven adjuvant for radiotherapy and
chemotherapy. Magnetic resonance guided high intensity focused ultrasound (MR-HIFU) …

Chronic pain is one of the leading causes of disability and disease burden worldwide,
accounting for a prevalence between 6.9% and 10% in the general population …

Objectives To assess the safety and feasibility of MRI-guided high-intensity focused
ultrasound (MR-HIFU) ablation in breast cancer patients using a dedicated breast platform …

Magnetic resonance guided high-intensity focused ultrasound (MR-HIFU) is a versatile
technology platform for noninvasive thermal therapies in oncology. Since MR-HIFU allows …

MRgFUS represents a minimally invasive treatment for uterine fibroids that is able to
improve the quality of life and fibroid size with durability. It is possible that MRgFUS could be …